Skip to content

FY2027 ICD-10-CM reference

E34.01: Carcinoid heart syndrome

By the HCC Buddy Coding Team

The official ICD-10-CM descriptor is Carcinoid heart syndrome. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.

Billable code. Verified against the official FY2027 order file.

CMS-HCC V28

  • HCC 17: Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic · RAF 4.209, Community Non-Dual Aged (CNA)

Payment year 2027, 2026 dates of service. HCC from the CMS 2027 Initial ICD-10-CM Mappings; RAF from the CMS-HCC V28 relative factors. For 2027 dates of service, CMS has not yet published the payment year 2028 mappings.

CMS-HCC V24

Not used for payment year 2027 Medicare Advantage payment

ESRD

Source verification pending

PACE

Source verification pending

RxHCC

Source verification pending

HHS-HCC

Source verification pending

FY2027 Tabular instructions

Instructions below include applicable chapter, section and parent-code notes. Each note identifies where it appears in the official source.

Instructional note

All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

Source: E00-E89 (chapter, inherited).

Excludes1

transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Source: E00-E89 (chapter, inherited).

Excludes1

galactorrhea (N64.3)

Source: E20-E35 (section, inherited).

Excludes1

gynecomastia (N62)

Source: E20-E35 (section, inherited).

Excludes1

pseudohypoparathyroidism (E20.1)

Source: E34 (category, inherited).

Code also

the underlying disorder, such as:

Source: E34.0 (self, inherited).

Code also

primary neuroendocrine tumors (C7A.-)

Source: E34.0 (self, inherited).

Code also

secondary neuroendocrine tumors (C7B.-)

Source: E34.0 (self, inherited).

Instructional note

Carcinoid heart disease

Source: E34.01 (self, direct).

Instructional note

Hedinger syndrome

Source: E34.01 (self, direct).

Source: CMS FY2027 Tabular List and Alphabetic Index.

Open Tabular instructions and code details

Compare the FY2027 additions, removals and billable-status changes

What does E34.01 mean in FY2027?

The official ICD-10-CM descriptor is Carcinoid heart syndrome. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.

Is E34.01 billable in FY2027?

The FY2027 order file marks E34.01 as billable. Check the complete Tabular instructions and documentation before assigning it.

Does E34.01 map to an HCC?

In the CMS 2027 Initial ICD-10-CM Mappings (payment year 2027, 2026 dates of service), E34.01 maps to CMS-HCC V28 HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic). For 2027 dates of service, CMS has not yet published the payment year 2028 mappings. ESRD, RxHCC, PACE and HHS-HCC mappings are still pending verification for FY2027.

Source: CMS FY2027 ICD-10-CM order file. Read the FY2027 Official Guidelines.

Review the FY2026 April edition